UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000013206
Receipt No. R000015333
Scientific Title efficacy and safety of Gemcitabine plus nab-paclitaxel in unresectable pancreas cancer
Date of disclosure of the study information 2014/02/20
Last modified on 2021/03/05 16:13:45

No. Disposal Last modified on Item of update
1 Insert 2014/02/20 14:54:23
2 Update 2014/12/22 19:18:50 Key secondary outcomes
Key secondary outcomes
3 Update 2014/12/22 19:38:07 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
4 Update 2014/12/22 19:39:10 Recruitment status
5 Update 2016/09/17 10:32:02 Control
6 Update 2016/09/17 10:33:09 Name of primary sponsor
Organization
Organization
Organization
7 Update 2021/03/05 16:13:45 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary sponsor
Institute
Email3
Organization
Organization
Address
Address
Tel
Email


Contact us.